Medtronic

For Media Professionals

Corporate Information

Medtronic at a Glance

Executive Management

Investor Information

Corporate Governance

This information is intended for media professionals and investors

Document Options

E-mail this page

Welcome to the Medtronic Newsroom. This resource is intended for investors and media professionals who are looking to learn more about Medtronic and the full range of solutions that we provide to those living with chronic disease.

Medtronic Resolute Integrity Receives FDA Approval

Read the press release

Media Kit Materials

Click here to see how it works

Most Recent Releases

Feb 21, 2012	Medtronic Reports Third Quarter Earnings
Feb 17, 2012	Medtronic Resolute Integrity™ Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease
Feb 16, 2012	Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2012
Feb 13, 2012	Medtronic Launches Two New Clinical Programs to Evaluate the Use of Symplicity™¹ Renal Denervation System Across Multiple Conditions
	Go to news releases >> >>

Click here to view Medtronic's Code of Conduct and the U.S. Business Conduct Standards.